GotoPER - Physicians' Education Resource
Back to Home
Free CE/CMEVideo

Medical Crossfire®: Experts Debate the Hottest Topics in AML – FLT3, IDH1/2, KMT2Ar, NPM1, Secondary AML, Maintenance, Novel Combinations, and Emerging Therapies

Create AccountAlready Registered? Login Here

Release Date

January 7, 2026

Expiration Date

January 8, 2027

Credits

3.0 CME, NCPD

Specialties

Hematologic Cancer, Medical Oncology+2 more

Release Date: January 7, 2026

Expiration Date: January 7, 2027

Activity Overview

This educational activity is an archive of the live presentation held on December 5, 2025.

For more information about this educational activity, the faculty, and disclosures, please click here.

Target Audience

This educational activity is directed toward physicians, nurses, NPs/PAs, pharmacists, and other HCPs involved in the diagnosis and treatment of AML.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Incorporate personalized care plans for patients with AML aligned with guideline-recommended molecular testing and risk stratification protocols
  • Evaluate emerging approaches for the management of patients with AML in the frontline, maintenance, and relapsed/refractory settings
  • Integrate evidence from recent clinical trials within the framework of treatment paradigms for AML
  • Develop effective strategies to monitor for and manage treatment-associated adverse events in patients with AML
Medical Crossfire®: Experts Debate the Hottest Topics in AML – FLT3, IDH1/2, KMT2Ar, NPM1, Secondary AML, Maintenance, Novel Combinations, and Emerging Therapies

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 3.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Kura Oncology; Rigel Pharmaceuticals; and Taiho Oncology.

Related Content

View All

Course

Medical Crossfire®: Experts Debate the Hottest Topics in AML – FLT3, IDH1/2, KMT2Ar, NPM1, Secondary AML, Maintenance, Novel Combinations, and Emerging Therapies

Create Account